Spectra for:
Frédéric Pelletier, Virginie Comte, Alexandre Massard, Margot Wenzel, Stéphanie Toulot, Philippe Richard, Michel Picquet, Pierre Le Gendre, Olivier Zava, Fabio Edafe, Angela Casini, Paul J. Dyson
Compound 1 [(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CH2)4-PPH2)_TICL2]
![[(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CH2)4-PPH2)_TICL2]](/api/compound/F5h6329roSF.png?h=300&w=458 "[(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CH2)4-PPH2)_TICL2]")
Compound 4 [(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CME2)-P(H)PH)_TICL2]
![[(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CME2)-P(H)PH)_TICL2]](/api/compound/4GR7Jz8zdKD.png?h=300&w=458 "[(ETA-(5)-C5H5)-(ETA-(5)-C5H4-(CME2)-P(H)PH)_TICL2]")
Compound 7 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)4-PPH2)_TICL2]_RUCL2]
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)4-PPH2)_TICL2]_RUCL2]](/api/compound/7bhfWxhVAVY.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)4-PPH2)_TICL2]_RUCL2]")
Compound 10 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]](/api/compound/CVi11Q6R4sP.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CME2)-P(H)PH)_TICL2]_RUCL2]")
Compound 13'*BF4 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER](/api/compound/kAfuJn1QpM.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)_TICL2]_RUCL]-(BF4);MAJOR_ISOMER")
Compound 13*BF4 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4);MINOR_ISOMER
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4);MINOR_ISOMER](/api/compound/HVNw6Fd7ZqN.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-(CH2)2-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4);MINOR_ISOMER")
Compound 14*BF4 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)](/api/compound/Ifpt7c4DkpB.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BF4)")
Compound 14*BPH4 [(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BPH4)
![[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BPH4)](/api/compound/hd49VdsmLr.png?h=300&w=458 "[(ETA-(6)-PARA-CYMENE-[(ETA-(5)-C5H5)-(MY-ETA-(5):KAPPA-(1)-C5H4-PPH2)-TICL-(MY-CL)]-RUCL]-(BPH4)")
LITHIUM_(1-METHYL-1-PHENYLPHOSPHINO)-ETHYLCYCLOPENTADIENIDE;LI-[C5H4-C-(CH3)2-P(H)PH]
![LITHIUM_(1-METHYL-1-PHENYLPHOSPHINO)-ETHYLCYCLOPENTADIENIDE;LI-[C5H4-C-(CH3)2-P(H)PH]](/api/compound/14FjkASMRyC.png?h=300&w=458 "LITHIUM_(1-METHYL-1-PHENYLPHOSPHINO)-ETHYLCYCLOPENTADIENIDE;LI-[C5H4-C-(CH3)2-P(H)PH]")
LITHIUM_(4-DIPHENYLPHOSPHINOBUTYL)-CYCLOPENTADIENIDE;LI-[C5H4-(CH2)4-PPH2]
![LITHIUM_(4-DIPHENYLPHOSPHINOBUTYL)-CYCLOPENTADIENIDE;LI-[C5H4-(CH2)4-PPH2]](/api/compound/BCgU3qi8SoG.png?h=300&w=458 "LITHIUM_(4-DIPHENYLPHOSPHINOBUTYL)-CYCLOPENTADIENIDE;LI-[C5H4-(CH2)4-PPH2]")
Citation
| Citation | J.MED.CHEM.,53,6923(2010) |
|---|---|
| Journal | Journal of Medicinal Chemistry |
| Issue | 19 |
| Volume | 53 |
| Page(s) | 6923-6933 |
| Year | 2010 |
| Author(s) | Frédéric Pelletier, Virginie Comte, Alexandre Massard, Margot Wenzel, Stéphanie Toulot, Philippe Richard, Michel Picquet, Pierre Le Gendre, Olivier Zava, Fabio Edafe, Angela Casini, Paul J. Dyson |
| Publisher | American Chemical Society (ACS) |
| DOI | 10.1021/jm1004804 |